Tapewire

Nasdaq · USD

SGMT

Sagimet Biosciences Inc.

Export transactions ↓
Tapewire entity
5273
SEC CIK
0001400118
Parsed reports
100

Last 12 months

Inside the activity.

0 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202604
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202603
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 18, 2023 Filed Jul 20, 2023 20:20 UTC GrantSeries A Common Stock 38,763 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-082736 · tm2321276-23_4seq1.xml · nonDerivative · entry 2

SEIDENBERG BETH C · CIK 0001184592 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 38,763

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F1 · price: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · ownership.nature: Represents shares held directly by KPCB Pandemic and Bio Defense Fund, LLC ("KPCB PBD"). The managing member of KPCB PBD is KPCB PBD Associates, LLC ("KPCB PBD Associates"). All securities are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:20 UTC Disposition to issuerCommon Stock 38,763 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-082736 · tm2321276-23_4seq1.xml · nonDerivative · entry 1

SEIDENBERG BETH C · CIK 0001184592 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 0

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F1 · price: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · ownership.nature: Represents shares held directly by KPCB Pandemic and Bio Defense Fund, LLC ("KPCB PBD"). The managing member of KPCB PBD is KPCB PBD Associates, LLC ("KPCB PBD Associates"). All securities are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The Reporting Person disclaims Section 16 beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of any of the reported shares for purposes of Section 16 or any other purpose.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:15 UTC GrantStock Option (Right to Buy) · Derivative 49,533 $0.00 Strike: $8.74 $0.00
Disclosure

SEC source: 0001104659-23-082720 · tm2321276-13_4seq1.xml · derivative · entry 2

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,533

Underlying: Series A Common Stock · 49,533 shares

Expires 2031-04-19

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option vest in forty-eight (48) equal monthly installments following April 16, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:15 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 49,533 $0.00 Strike: $8.74 $0.00
Disclosure

SEC source: 0001104659-23-082720 · tm2321276-13_4seq1.xml · derivative · entry 1

GRAMMER ELIZABETH A · CIK 0001213041 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 49,533 shares

Expires 2031-04-19

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option vest in forty-eight (48) equal monthly installments following April 16, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC GrantStock Option (Right to Buy) · Derivative 23,839 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082732 · tm2321276-20_4seq1.xml · derivative · entry 6

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,839

Underlying: Series A Common Stock · 23,839 shares

Expires 2031-01-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 23,839 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082732 · tm2321276-20_4seq1.xml · derivative · entry 5

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,839 shares

Expires 2031-01-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC GrantStock Option (Right to Buy) · Derivative 23,216 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082732 · tm2321276-20_4seq1.xml · derivative · entry 4

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,216

Underlying: Series A Common Stock · 23,216 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 23,216 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082732 · tm2321276-20_4seq1.xml · derivative · entry 3

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,216 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC GrantStock Option (Right to Buy) · Derivative 1,976 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082732 · tm2321276-20_4seq1.xml · derivative · entry 2

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,976

Underlying: Series A Common Stock · 1,976 shares

Expires 2025-03-09

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 1,976 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082732 · tm2321276-20_4seq1.xml · derivative · entry 1

Rodgers Richard J · CIK 0001313397 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,976 shares

Expires 2025-03-09

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:19 UTC
Rozek ElizabethGeneral Counsel and CCO
GrantStock Option (Right to Buy) · Derivative 242,142 $0.00 Strike: $13.51 $0.00
Disclosure

SEC source: 0001104659-23-082734 · tm2321276-21_4seq1.xml · derivative · entry 2

Rozek Elizabeth · CIK 0001975022 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,142

Underlying: Series A Common Stock · 242,142 shares

Expires 2033-04-19

F1 · timeliness: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:19 UTC
Rozek ElizabethGeneral Counsel and CCO
Disposition to issuerStock Option (Right to Buy) · Derivative 242,142 $0.00 Strike: $13.51 $0.00
Disclosure

SEC source: 0001104659-23-082734 · tm2321276-21_4seq1.xml · derivative · entry 1

Rozek Elizabeth · CIK 0001975022 · General Counsel and CCO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 242,142 shares

Expires 2033-04-19

F1 · timeliness: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC
Rimac Anthony MChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 242,142 $0.00 Strike: $13.51 $0.00
Disclosure

SEC source: 0001104659-23-082730 · tm2321276-19_4seq1.xml · derivative · entry 2

Rimac Anthony M · CIK 0001604562 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,142

Underlying: Series A Common Stock · 242,142 shares

Expires 2033-04-19

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:18 UTC
Rimac Anthony MChief Operating Officer
Disposition to issuerStock Option (Right to Buy) · Derivative 242,142 $0.00 Strike: $13.51 $0.00
Disclosure

SEC source: 0001104659-23-082730 · tm2321276-19_4seq1.xml · derivative · entry 1

Rimac Anthony M · CIK 0001604562 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 242,142 shares

Expires 2033-04-19

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 23,839 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 14

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,839

Underlying: Series A Common Stock · 23,839 shares

Expires 2031-01-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 23,839 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 13

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,839 shares

Expires 2031-01-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 23,216 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 12

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,216

Underlying: Series A Common Stock · 23,216 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 23,216 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 11

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 23,216 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 144 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 10

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144

Underlying: Series A Common Stock · 144 shares

Expires 2025-02-05

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 144 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 9

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 144 shares

Expires 2025-02-05

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 3,349 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 8

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,349

Underlying: Series A Common Stock · 3,349 shares

Expires 2024-12-16

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 3,349 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 7

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,349 shares

Expires 2024-12-16

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 2,086 $0.00 Strike: $11.13 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 6

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,086

Underlying: Series A Common Stock · 2,086 shares

Expires 2024-03-12

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 2,086 $0.00 Strike: $11.13 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 5

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,086 shares

Expires 2024-03-12

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC ConversionSeries E Preferred Stock · Derivative 327,309 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · derivative · entry 4

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Series A Common Stock · 4,117 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · kind: Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F1 · derivative.expiration_date: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC ConversionSeries A Common Stock 4,117 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · nonDerivative · entry 3

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,794

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date.

F2 · price: Upon closing of the Issuer's initial public offering, each share of Series E Preferred Stock automatically converted on a 79.4784-to-one basis into shares of the Issuer's Series A Common Stock. The Series E Preferred Stock had no expiration date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantSeries A Common Stock 8,677 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · nonDerivative · entry 2

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,677

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F1 · price: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerCommon Stock 8,677 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-23-082729 · tm2321276-18_4seq1.xml · nonDerivative · entry 1

Parsey Merdad · CIK 0001792150 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F1 · price: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 21,173 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 16

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,173

Underlying: Series A Common Stock · 21,173 shares

Expires 2032-10-16

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F4 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on October 17, 2023, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 21,173 $0.00 Strike: $7.15 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 15

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 21,173 shares

Expires 2032-10-16

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F4 · derivative.exercise_date: 25% of the shares underlying this option shall vest and become exercisable on October 17, 2023, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 526,332 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 14

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 526,332

Underlying: Series A Common Stock · 526,332 shares

Expires 2031-01-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option vest and become exercisable in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 526,332 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 13

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 526,332 shares

Expires 2031-01-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F3 · derivative.exercise_date: The shares underlying this option vest and become exercisable in forty-eight (48) equal monthly installments following January 27, 2021, subject to the Reporting Person's continued service on each such vesting date.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 46,432 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 12

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,432

Underlying: Series A Common Stock · 46,432 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 46,432 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 11

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 46,432 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 367,824 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 10

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 367,824

Underlying: Series A Common Stock · 367,824 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 367,824 $0.00 Strike: $6.36 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 9

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 367,824 shares

Expires 2029-04-27

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 26,352 $0.00 Strike: $19.87 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 8

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,352

Underlying: Series A Common Stock · 26,352 shares

Expires 2025-10-12

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 26,352 $0.00 Strike: $19.87 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 7

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 26,352 shares

Expires 2025-10-12

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 7,147 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 6

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,147

Underlying: Series A Common Stock · 7,147 shares

Expires 2024-12-16

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 7,147 $0.00 Strike: $23.05 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 5

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,147 shares

Expires 2024-12-16

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 3,179 $0.00 Strike: $11.13 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 4

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,179

Underlying: Series A Common Stock · 3,179 shares

Expires 2024-03-12

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 3,179 $0.00 Strike: $11.13 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 3

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,179 shares

Expires 2024-03-12

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC GrantStock Option (Right to Buy) · Derivative 5,630 $0.00 Strike: $0.79 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 2

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,630

Underlying: Series A Common Stock · 5,630 shares

Expires 2023-09-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document
July 18, 2023 Filed Jul 20, 2023 20:17 UTC Disposition to issuerStock Option (Right to Buy) · Derivative 5,630 $0.00 Strike: $0.79 $0.00
Disclosure

SEC source: 0001104659-23-082726 · tm2321276-16_4seq1.xml · derivative · entry 1

Kemble George · CIK 0001858176 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,630 shares

Expires 2023-09-26

F1 · kind: Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Common Stock was reclassified into one share of Series A Common Stock.

F2 · derivative.exercise_date: This option is fully vested and exercisable as of the date hereof.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.